Kerry Utton joins European Life Sciences Organisation Sciensus

• Sciensus announces Kerry Utton’s appointment into the company
• After the declaration, she joined the business leading of company’s Corporate Strategy function

Sciensus, a European life sciences organisation has made an announcement regarding the appointment of Kerry Utton since it continues to reinforce its pharma capabilities. In addition, Kerry has joined the business leading of company’s Corporate Strategy function.

Kerry is a seasoned leader, armed with more than 25 years of experience in pharmaceutical and life sciences. Prior to joining in this firm, she was working with Syneos Health for seven long years, occupying diverse roles over the years. Some of her other career experiences include INC Research where she worked as a member of the company’s senior leadership team for eight years, playing a role in establishing the PMO while launching novel technologies. She also took care of operationalising mergers & acquisitions, assisting the organisation via a period of rapid growth.

Expressing her excitement, Kerry says, “I’m excited to join Sciensus and bring my experience into this important sector of patient healthcare. I’m looking forward to working with my new colleagues as we seek to achieve our organisational objective of supporting a broader range of patients achieve better healthcare outcomes.”

Moreover, Sciensus CEO Christian Tucat expressed his happiness, stating, “I’m delighted to have Kerry join us at such an important time in our growth journey. Kerry brings a wealth of expertise to Sciensus and will play a pivotal role in accelerating new, strategic capability development and expand our geographic reach. In doing so, this will empower patients to achieve better health outcomes overall and drive our commercial success.”

Founded in 1992, Sciensus caters in the Hospitals and Health Care industry with headquarters in London, England. The firm focuses on accelerating access to lifesaving medicines of the patients.